Adverse effects of arsenic exposure on uterine function and structure in female rat

Experimental and Toxicologic Pathology

Volumn 62, Issue 4, 2010, Pages 451-459

  Akram, Zertashia ^a   Jalali, Samina ^a   Shami, Sajjad Aslam ^a   Ahmad, Laiq ^a   Batool, Sajida ^a   Kalsoom, Ommia ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Endometrium; Epithelium; FSH; LH; Rat; Sodium arsenite; Steroid hormones; Uterine; Uterine gland

Indexed keywords

ARSENITE SODIUM; DRINKING WATER; ENDOCRINE DISRUPTOR; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARSENIC POISONING; ARTICLE; ATOMIC ABSORPTION; BASEMENT MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM; EXPOSURE; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; RAT; REPRODUCTIVE HEALTH; TISSUE STRUCTURE; UTERUS; UTERUS FUNCTION; UTERUS WEIGHT;

ANIMALS; ARSENITES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; MYOMETRIUM; ORGAN SIZE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; SODIUM COMPOUNDS; SPECTROPHOTOMETRY, ATOMIC; UTERUS; WATER POLLUTANTS, CHEMICAL;

RATTUS;

EID: 77953621251     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.07.008     Document Type: Article

References (49)

1. Ahmad S.A., Sayed S.U., Barua S., Khan M.H., Faruquee M.H., Jalil A., et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001, 109:629-631.
2. Arnold L.L., Cano M., St John M., Eldna M., vanGermat M., Cohen S.M. Effects of dietry dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 1999, 20:2171-2179.
3. Bates M.N., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Kalman D., et al. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 2004, 159:381-389.
4. Beltran-Gracio M.J., Espinose A., Herrera N., Petrez-Zapata A.J., Beltran-Gracia C., Ogura T. Formation of copper oxychloride and reactive oxygen species as causes of uterine injury during copper oxidation of Cu-IUD. Contraception 2000, 61:99-103.
5. Borzsonyi M., Bereczky A., Rudnai P., Scanady M., Horvath A. Epidemiological studies on human subjects exposed to arsenic in drinking water in Southeast Hungary. Arch Toxicol 1992, 66:77-78.
6. Bredhult C., Bäcklin B.M., Olovsson M. Effects of chlorinated biphenyls and metabolites on human uterine myocyte proliferation. Hum Exp Toxicol 2007, 26:801-809.
7. Chattopadhyay A., Ghosh S., Chaki S., Debnath J., Ghosh D. Effect of sodium arsenite on plasma levels of gonadotropins and ovarian steroidogenesis in mature albino rats: duration dependent response. J Toxicol Sci 1999, 24:425-431.
8. Chattopadhyay S., Ghosh S., Debnath J., Ghosh D. Protection of sodium arsenite-induced ovarian toxicity by coadministration of l-ascorbate (Vitamin C) in mature Wister strain rat. Arch Environ Contam Toxicol 2001, 41:83-89.
9. Chattopadhyay S., Ghosh S.P., Ghosh D., Debnato J. Effect of dietary co-administration of sodium selenite on sodium arsenite-induced ovarian and uterine disorders in mature albino rats. Toxicol Sci 2003, 75:412-422.
10. Davey J.C., Bodwell J.E., Gosse J.A., Hamilton J.W. Arsenic as an endocrine disruptor: effect of arsenic on estrogen receptor mediated gene expression in vivo and in cell culture. Toxicol Sci 2007, 98:75-86.
11. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 2001, 174:282-293.
12. Duker A.A., Carranza E.J.M., Hale M. Arsenic geochemistry and health. Environ Internat 2005, 31:631-641.
13. Fazleabas A.T., Strakova Z. Endometrial function: cell specific changes in the uterine environment. Mol Endocrinol 2002, 186:143-147.
14. Germolec D.R., Spalding T., Boorman G.A., Wilmer J.L., Tennant R., Burleson F., et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factor. Mutat Res 1997, 386:209-218.
15. Gray C.A., Bartol F.F., Tarleton B.J., Wiley A.A., Johnson G.A., Bazer I.W., et al. Developmental biology of uterine gland. Bio Reprod 2001, 65:1311-1323.
16. Hall M., Gamble M., Slavkovich V., Liu X., Levy D., Cheng Z., et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 2007, 115:1503-1509.
17. Heck J.F., Chen Y., Grann V.R., Slavkovich V., Parvez F., Ahsan H. Arsenic exposure and anemia in Bangladesh: a population-based study. J Occup Environ Med 2006, 50:80-87.
18. Holson J.F., DeSesso J.M., Jacobson C.F. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic. Teratology 2000, 62:51-71.
19. Hopenhayn C., Bush H.M., Bingcang A., Hertz-Picciotto I. Association between arsenic exposure from drinking water and anemia during pregnancy. J Occup Environ Med 2006, 48:635-643.
20. Hopenhayn C., Ferreccio C., Browning S.R., Haung B., Peralta C., Gibb H., et al. Arsenic exposure from drinking water and birth weight. Epidemiology 2003, 14:593-602.
21. Hopenhayn C., Huang B., Christian J., Peralta C., Ferreccio C., Atallah R., et al. Profile of urinary arsenic metabolites during pregnancy. Environ Health Prespect 2003, 111:1888-1891.
22. Hopenhayn-Rich C., Browning S.R., Hertz-Picciotto I., Ferrsccio C., Peralta C., Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 2000, 108:667-673.
23. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002, 133:1-16.
24. Hughes M.F., Kenyon E.M., Kitchin K.T. Research approaches to address uncertainties in the risk assessment of arsenic in drinking water. Toxicol Appl Pharmacol 2007, 222:399-404.
25. Jana D., Nandi D., Maiti R.K., Ghosh D. Effect of human chrionic gonadotropin coadministration on the activities of ovarian Δ5-3β-hydroxysteriod dehydrogenase, and 17β-hydroxysteriod dehydrogenase, and ovarian and uterine histology in lithium chloride-treated albino rats. Repro Toxicol 2001, 15:215-219.
26. Kapaj S., Peterson H., Liber K., Bhattacharya P. Human health effects from chronic arsenic poisoning - a review. J. Environ Sci Health A Tox Hazard Subst Environ Eng 2006, 41:2399-2428.
27. Kitchin K.T. Recent research in arsenic carcinogenesis: modes of action, animal model system, and methylated arsenic metabolites. Toxicol Appl Pharmacol 2001, 172:249-261.
28. Lessey B.A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003, 68:809-815.
29. Longnecker M.P., Danials J.L. Environmental contaminations as etiologic factors for diabetes. Environ Health Perspect 2001, 69:871-876.
30. Mandal B.K., Ogra Y., Anzai K., Suzuki K.T. Speciation of arsenic in biological samples. Toxicol Appl Pharmacol 2004, 198:307-318.
31. Mann G.E., Lamming G.E. Relationship between maternal endocrine environment, early embryo development and inhibition of the luteolytic mechanism in cows. Reproduction 2001, 121:175-180.
32. Mann G.E., Green M.P., Sinclair K.D., Demmers K.J., Fray M.D., Gutierrez C.G., et al. Effects of circulating progesterone and insulin on early embryo development in beef heifers. Anim Reprod Sci 2003, 79:71-79.
33. Mazumder G.D.N. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003, 38:141-163.
34. Milton A.H., Smith W., Rahman B., Hassan Z., Kulsum U., Dear K., et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005, 16:82-86.
35. Mittal M., Flora S.J. Effects of individual and combined exposure to sodium arsenite and sodium fluoride on tissue oxidative stress, arsenic and fluoride levels in male mice. Chem Biol Interact 2006, 162:128-139.
36. Mukherjee A., Sengupta M.K., Hossain M.A., Ahmad S., Das B., Nayak B., et al. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 2006, 24:142-163.
37. Nandi D., Patra R.C., Swarup D. Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats. Toxicology 2005, 211:26-35.
38. Nephew K.P., Long X., Osborne E., Burke K.A., Ahluwalia A., Bigsby R.M. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod 2000, 62:168-177.
39. +/- lame mice. Toxicologist 2000, 54:134-140.
40. Rahman M., Tondel M., Ahmad S.A., Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 1998, 148:198-203.
41. Singh N., Kumar D., Sabu A.P. Arsenic in the environment: effects on human health and possible prevention. J Environ Biol 2007, 28:359-365.
42. Slayden O.D., Brenner R.M. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol 2004, 67:393-409.
43. Steinmaus C., Bates M.N., Yaun Y., Kalman D., Atallah R., Rey O.A., et al. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J Occup Med 2006, 48:478-488.
44. Sugino N. The role of oxygen radical-mediated signaling pathways in endometrial function. Placenta 2007, 133-136.
45. Sugino N., Shimamura K., Takiguchi S., Tamura H., Ono M., Nakata M., et al. Changes in activity of superoxide dismutase in the human endometrium throughout the menstrual cycle and in early pregnancy. Hum Reprod 1996, 11:1073-1078.
46. Tseng C.H., Tai T.Y., Chong C.K., Tseng C.P., Lai M.S., Lin B.J., et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseiasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000, 108:847-851.
47. Tseng C.H., Tseng C.P., Chiou H.Y., Hsueh Y.M., Chong C.K., Chen C.J. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol Lett 2002, 133:69-76.
48. Waalkes M.P., Liu J., Ward J.M., Diwan B.A. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol 2004, 198:377-384.
49. Waalkes M.P., Ward J.M., Liu J., Diwan B.A. Tranplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 2003, 186:7-17.